proadifen has been researched along with Myocardial Infarction in 1 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berges, A | 1 |
| Van Nassauw, L | 1 |
| Timmermans, JP | 1 |
| Vrints, C | 1 |
1 other study available for proadifen and Myocardial Infarction
| Article | Year |
|---|---|
Role of nitric oxide during coronary endothelial dysfunction after myocardial infarction.
Topics: Adenosine; Amidines; Animals; Benzylamines; Bradykinin; Coronary Circulation; Cytochrome P-450 Enzym | 2005 |